Skip to main content
    Q

    QuidelOrtho Corp (QDEL)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $10.21
    -0.53 (-4.93%)

    Market Cap: $736.90M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    QuidelOrtho Corp (QDEL) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    QuidelOrtho (QDEL) trades at 11.9x trailing earnings and 0.3x sales. Its P/E of 11.9x is below its 5-year median of 12.3x. Its forward P/E is 9.6x. The median P/E across 5 similar companies is 23.7x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 24.0% higher over the next year.

    MultipleValue
    P/E (trailing)11.9x
    Forward P/E9.6x
    Price to sales0.3x
    Price to book0.4x
    EV/EBITDA10.6x
    PEG2.1
    FCF yield-16.8%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 24.2% below 15.7x, its P/S is 89.7% below 2.9x and its P/B is 87.1% below 3.1x.

    MultipleCurrent5-year median10-year median
    P/E11.9x12.3x15.7x
    P/S0.3x1.1x2.9x
    P/B0.4x0.9x3.1x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 116 to 120 months (10-year).

    Valuation History

    Over the 9 of the 10 year ends shown that have a P/E, its P/E ranged from 4.9x in 2022 to 58.6x in 2017.

    Year endPriceP/EP/SP/B
    2025$28.5613.5x0.7x1.0x
    2024$44.5524.1x1.1x1.0x
    2023$73.7017.8x1.6x1.0x
    2022$85.674.9x1.4x1.2x
    2021$134.997.6x3.4x3.0x
    2020$179.659.0x4.7x5.9x
    2019$75.0325.3x6.0x5.8x
    2018$48.8216.1x3.9x4.9x
    2017$43.3558.6x5.3x6.6x
    2016$21.42N/A3.7x3.5x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About QDEL

    What is QDEL's forward P/E ratio?

    QuidelOrtho has a forward P/E ratio of 9.6x.

    Is QDEL stock overvalued?

    GNG's valuation label for QDEL is Undervalued. Its P/E of 11.9x compares with a median of 23.7x across 5 similar companies.

    What is QDEL's price to sales ratio?

    QuidelOrtho has a price to sales ratio of 0.3x.

    What is QuidelOrtho's average P/E ratio over 5 years?

    QuidelOrtho's median P/E over the last 5 years is 12.3x, from 60 month-end values through Oct 2026.

    What is QDEL's PEG ratio?

    QuidelOrtho has a PEG ratio of 2.1.